Lemaitre Vascular (LMAT) Share-based Compensation (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Share-based Compensation for 17 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation changed 0.46% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $10.8 million, a 47.72% increase from a year earlier, with the FY2025 full-year figure at $20.4 million, up 11.48% from the prior year.
• Share-based Compensation was $1.9 million for Q2 2026 at Lemaitre Vascular, down from $5.1 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $5.1 million in Q1 2026 and troughed at $684000.0 in Q4 2022.
• A 5-year average of $1.7 million and a median of $1.6 million in 2024 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation declined 22.8% in 2022 and soared 147.8% in 2026, its largest moves.
• Over 5 years, Share-based Compensation stood at $684000.0 in 2022, then surged by 105.26% to $1.4 million in 2023, then increased by 23.86% to $1.7 million in 2024, then increased by 20.53% to $2.1 million in 2025, then retreated by 7.68% to $1.9 million in 2026.
• The last three Share-based Compensation figures came in at $1.9 million (Q2 2026), $5.1 million (Q1 2026), and $2.1 million (Q4 2025), per Business Quant data.